Literature DB >> 22547132

Editorial: HDAC inhibition begets more MDSCs.

Pavan Reddy.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22547132      PMCID： PMC3973988          DOI： 10.1189/jlb.1111541

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN： 0741-5400            Impact factor:   4.962


× No keyword cloud information.
  27 in total

Review 1.  Acetylation: a regulatory modification to rival phosphorylation?

Authors:  T Kouzarides
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

Review 2.  Cooperation between complexes that regulate chromatin structure and transcription.

Authors:  Geeta J Narlikar; Hua-Ying Fan; Robert E Kingston
Journal:  Cell       Date:  2002-02-22       Impact factor: 41.582

Review 3.  Chromatin modifications and their function.

Authors:  Tony Kouzarides
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

4.  Stat3 dimerization regulated by reversible acetylation of a single lysine residue.

Authors:  Zheng-Long Yuan; Ying-Jie Guan; Devasis Chatterjee; Y Eugene Chin
Journal:  Science       Date:  2005-01-14       Impact factor: 47.728

5.  Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors.

Authors:  M S Finnin; J R Donigian; A Cohen; V M Richon; R A Rifkind; P A Marks; R Breslow; N P Pavletich
Journal:  Nature       Date:  1999-09-09       Impact factor: 49.962

6.  The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines.

Authors:  Flavio Leoni; Andrea Zaliani; Giorgio Bertolini; Giulia Porro; Paolo Pagani; Pietro Pozzi; Giancarlo Donà; Gianluca Fossati; Silvano Sozzani; Tania Azam; Philip Bufler; Giamila Fantuzzi; Igor Goncharov; Soo-Hyun Kim; Benjamin J Pomerantz; Leonid L Reznikov; Britta Siegmund; Charles A Dinarello; Paolo Mascagni
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

7.  Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function.

Authors:  Jennifer L Brogdon; Yongyao Xu; Susanne J Szabo; Shaojian An; Francis Buxton; Dalia Cohen; Qian Huang
Journal:  Blood       Date:  2006-09-28       Impact factor: 22.113

8.  Histone deacetylase inhibition facilitates GM-CSF-mediated expansion of myeloid-derived suppressor cells in vitro and in vivo.

Authors:  Brian R Rosborough; Antonino Castellaneta; Sudha Natarajan; Angus W Thomson; Heth R Turnquist
Journal:  J Leukoc Biol       Date:  2011-10-25       Impact factor: 4.962

Review 9.  Histone-deacetylase inhibitors: novel drugs for the treatment of cancer.

Authors:  Ricky W Johnstone
Journal:  Nat Rev Drug Discov       Date:  2002-04       Impact factor: 84.694

10.  Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.

Authors:  Pavan Reddy; Yoshinobu Maeda; Kevin Hotary; Chen Liu; Leonid L Reznikov; Charles A Dinarello; James L M Ferrara
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-04       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.